Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
Sherman M, Peltekian KM, Lee C. Sherman M, et al. Among authors: peltekian km. Hepatology. 1995 Aug;22(2):432-8. Hepatology. 1995. PMID: 7543434 Clinical Trial.
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?
Peltekian KM, Bain VG, Lee SS, Sherman M, Cooper CL, Yoshida EM, Marotta PJ, Krajden M, Balshaw R, DeschĂȘnes M. Peltekian KM, et al. Ann Hepatol. 2011 Jul-Sep;10(3):260-9. Ann Hepatol. 2011. PMID: 21677327
Blue-Print for Elimination of Hepatitis C Viral Infection: One Step Closer.
Peltekian KM. Peltekian KM. Ann Hepatol. 2017 Sep-Oct;16(5):696-698. doi: 10.5604/01.3001.0010.2703. Ann Hepatol. 2017. PMID: 28809738 Free article. No abstract available.
Burden of disease and cost of chronic hepatitis C infection in Canada.
Myers RP, Krajden M, Bilodeau M, Kaita K, Marotta P, Peltekian K, Ramji A, Estes C, Razavi H, Sherman M. Myers RP, et al. Can J Gastroenterol Hepatol. 2014 May;28(5):243-50. doi: 10.1155/2014/317623. Can J Gastroenterol Hepatol. 2014. PMID: 24839620 Free PMC article. Review.
Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection.
Ding JW, Ning Q, Liu MF, Lai A, Peltekian K, Fung L, Holloway C, Yeger H, Phillips MJ, Levy GA. Ding JW, et al. Adv Exp Med Biol. 1998;440:609-18. doi: 10.1007/978-1-4615-5331-1_79. Adv Exp Med Biol. 1998. PMID: 9782336
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial.
Chatterjee A, Swain MG, Lee SS, Bain VG, Peltekian K, Croitoru K, Adams PC, Kaita K, Teitel J, Heathcote EJ. Chatterjee A, et al. Can J Gastroenterol. 2007 Feb;21(2):91-5. doi: 10.1155/2007/817198. Can J Gastroenterol. 2007. PMID: 17299612 Free PMC article. Clinical Trial.
Review article: the changing epidemiology of hepatocellular carcinoma in Canada.
Dyer Z, Peltekian K, van Zanten SV. Dyer Z, et al. Aliment Pharmacol Ther. 2005 Jul 1;22(1):17-22. doi: 10.1111/j.1365-2036.2005.02504.x. Aliment Pharmacol Ther. 2005. PMID: 15963075 Review.
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.
Sherman M, Yoshida EM, Deschenes M, Krajden M, Bain VG, Peltekian K, Anderson F, Kaita K, Simonyi S, Balshaw R, Lee SS; Canadian Pegasys Study Group. Sherman M, et al. Gut. 2006 Nov;55(11):1631-8. doi: 10.1136/gut.2005.083113. Epub 2006 May 18. Gut. 2006. PMID: 16709661 Free PMC article. Clinical Trial.
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, Leduc R, Peltekian K, Wong F, Margulies M, Heathcote EJ. Villeneuve JP, et al. Hepatology. 2000 Jan;31(1):207-10. doi: 10.1002/hep.510310130. Hepatology. 2000. PMID: 10613747
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
Powis J, Peltekian KM, Lee SS, Sherman M, Bain VG, Cooper C, Krajden M, Deschenes M, Balshaw RF, Heathcote EJ, Yoshida EM; Canadian Pegasys Study Group. Powis J, et al. Among authors: peltekian km. J Viral Hepat. 2008 Jan;15(1):52-7. doi: 10.1111/j.1365-2893.2007.00889.x. J Viral Hepat. 2008. PMID: 18088245 Free PMC article. Clinical Trial.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback